Oracle Investment Management as of March 31, 2015
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 28 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Accelr8 Technology Corporation | 15.5 | $122M | 5.4M | 22.50 | |
| Quidel Corporation | 10.0 | $79M | 2.9M | 26.98 | |
| Opko Health (OPK) | 8.9 | $70M | 5.0M | 14.17 | |
| NxStage Medical | 8.2 | $65M | 3.8M | 17.30 | |
| Thoratec Corporation | 6.5 | $52M | 1.2M | 41.89 | |
| Chimerix (CMRX) | 4.6 | $36M | 964k | 37.69 | |
| Acorda Therapeutics | 4.4 | $35M | 1.0M | 33.28 | |
| Transition Therapeutics | 4.2 | $33M | 4.9M | 6.83 | |
| Tesaro | 4.0 | $32M | 556k | 57.40 | |
| Intrexon | 4.0 | $31M | 693k | 45.37 | |
| Accuray Incorporated (ARAY) | 4.0 | $31M | 3.4M | 9.30 | |
| Raptor Pharaceuticals | 3.7 | $29M | 2.7M | 10.87 | |
| Mazor Robotics Ltd. equities | 3.1 | $25M | 2.2M | 11.23 | |
| Hansen Medical | 2.9 | $23M | 26M | 0.87 | |
| Regulus Therapeutics | 2.8 | $22M | 1.3M | 16.94 | |
| Biolase Technology | 2.7 | $21M | 11M | 2.02 | |
| Pacific Biosciences of California (PACB) | 2.4 | $19M | 3.3M | 5.84 | |
| Vermillion | 1.8 | $14M | 8.1M | 1.77 | |
| Amarin Corporation (AMRN) | 1.5 | $12M | 5.1M | 2.34 | |
| WebMD Health | 1.3 | $10M | 238k | 43.83 | |
| shares Agenus | 0.8 | $6.0M | 1.2M | 5.13 | |
| Metabolix | 0.6 | $4.5M | 7.3M | 0.62 | |
| Plasmatech Biopharmaceutical | 0.5 | $4.2M | 1.3M | 3.14 | |
| Biogen Idec (BIIB) | 0.4 | $3.3M | 7.7k | 422.25 | |
| Cerus Corporation (CERS) | 0.3 | $2.8M | 660k | 4.17 | |
| Second Sight Med Prods | 0.3 | $2.7M | 210k | 12.82 | |
| Momenta Pharmaceuticals | 0.3 | $2.2M | 148k | 15.20 | |
| Ladenburg Thalmann Financial Services | 0.1 | $432k | 112k | 3.86 |
